Nutex Health Inc. (NUTX) Fair Value 2026

NUTX · Medical Care Facilities ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

8.4 /10

32 fundamental signals · 9 models active

Value Trap Risk

SAFE (18/100)

Quick Summary — As of 2026-08-28, Nutex Health Inc. (NUTX) trades at $189.25, versus a $251.83 median fair value across its 9 active models — 33.1% above the current price. QOC: 8.4/10. Value Trap Risk: 18/100 (SAFE). 9/13 models active. Within that set, the Bayesian DCF component alone returns $132.02.

Key Facts

Ticker
NUTX
Price
$189.25
Quality Score
8.4/10
Value Trap Risk
18/100
Models Active
9/13
Last Updated
Strength: First Chicago suggests +217.5% upside with 57% confidence
Risk: Limited model coverage (9/13) may reduce confidence

Is Nutex Health Inc. (NUTX) Undervalued or Overvalued in 2026?

According to CirclFi’s 9-model valuation engine, Nutex Health Inc. (NUTX) appears undervalued as of : the median of 9 independent fair value estimates is $251.83, 33.1% above the current price of $189.25. Estimates range from $85.09 to $600.78. NUTX scores 8.4/10 on fundamental quality and 18/100 on value-trap risk.

For context, the median US equity CirclFi rates trades at an implied -23.4% versus its own 13-model consensus, across 3,809 rated companies as of 2026-08-28. NUTX’s +33.1% gap is wider than that market norm, and the Medical Care Facilities sector median is -28.3%. Full market index →

This verdict compares price to intrinsic value only — it is not a buy or sell rating. For the decision case (bull vs bear arguments, risk factors, peers), read Should You Buy Nutex Health Inc. Stock in 2026? →

What Fair Value Does Each Model Give NUTX?

9 Intrinsic Value Models vs. Current Price ($189.25)

Core Models (Unlocked)
Model Fair Value Upside
Intrinsic · High Conviction
 $132.02 -30.2%
Ensemble · Low Conviction
 $251.83 +33.1%
Scenario · High Conviction
 $600.78 +217.5%
Intrinsic · High Conviction
 $149.03 -21.3%
Unlock the Full Matrix

Access 5 additional models including ML-RIV, Regime Cross-Sectional, and more.

$1.30 / day

Billed monthly ($39/mo) or annually ($299/yr)

Unlock All 9 Models →

Cancel anytime · No contracts · Instant access

What Is NUTX's Fair Value Range?

Spread across 9 independent models · $85.09 to $600.78

CirclFi's 9 active models place Nutex Health Inc. (NUTX) between $85.09 and $600.78 per share, a spread of 205% of the median. The median of that range — $251.83 — is the fair value CirclFi publishes for NUTX, against a current price of $189.25.

Low · ML-RIVHigh · First Chicago
$85.09median $251.83$600.78
Where the range comes from
Most bearish modelML Residual Income$85.09
Most bullish modelFirst Chicago$600.78
Model agreement5 bullish · 4 bearishwide

A band this wide is itself the finding. When independent methods land far apart, they are reading a business whose value depends heavily on which lens you apply — volatile earnings, heavy reinvestment, or an asset base that cash-flow and asset-based methods score differently. That disagreement is information: it says the choice of method matters more than usual for NUTX. Treat the median as one reading among several and compare the individual models below before acting.

Every figure above is one model's standalone output on NUTX, not a CirclFi price target. How each model works →

What Is Nutex Health Inc. (NUTX) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, Nutex Health Inc.'s intrinsic value is estimated at $251.83, suggesting a +33.1% median upside from the current price of $189.25. While 5 models see room for appreciation, model agreement is not unanimous as 4 models flag potential overvaluation. Model dispersion is worth noting: First Chicago targets $600.78 (+217.5%), versus ML-RIV at $85.09 (-55.0%). This +272.5% range highlights the importance of multi-model analysis rather than relying on any single methodology.

What Do the Models Say About NUTX?

9 of 13 models are currently active for NUTX. Of these, 5 models suggest upside while 4 models suggest overvaluation. Taken together, their median fair value for NUTX is $251.83 — the figure CirclFi publishes as this stock's fair value. One component of that median, the Bayesian DCF, returns $132.02 on its own, implying -30.2% downside from the current price. See which stocks rank higher →

How Does NUTX Rank in Medical Care Facilities?

Among 60 Medical Care Facilities stocks, NUTX ranks #7 by Quality of Company score. CirclFi's QOC score of 8.4/10 evaluates 32 fundamental signals. A score of 8.4 places NUTX in the top tier.

See all Most Undervalued Medical Care Facilities Stocks →

Nutex Health Inc. operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.

Is NUTX a Value Trap?

CirclFi's Value Trap algorithm assigns NUTX a score of 18/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

9 of 13 models are active for Nutex Health Inc.. Moderate coverage provides meaningful perspective. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi 32-factor quality framework, Nutex Health Inc.'s fundamental quality profile registers 8.4/10. This robust score captures the company's profitability depth, growth consistency, balance sheet resilience, and shareholder return track record.

The gap between the most bullish and bearish model spans +272.5% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every NUTX valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across NUTX's 9 active models, average confidence is 46%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Nutex Health Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Medical Care Facilities Stocks Should You Also Analyze?

11 related Medical Care Facilities stocks with 13-model coverage

OPCHOption Care Health, Inc.QOC 8.4THCTenet Healthcare CorporationQOC 8.3ENSGThe Ensign Group, Inc.QOC 8.5PNTGThe Pennant Group, Inc.QOC 8.3UHSUniversal Health Services, Inc.QOC 8.5CHEChemed CorporationQOC 8.2LFSTLifeStance Health Group, Inc.QOC 7.2CCMConcord Medical Services Holdings LimitedQOC 6.1PIIIP3 Health Partners Inc.QOC 4.7ADUSAddus HomeCare CorporationQOC 8.9NHCNational HealthCare CorporationQOC 8.7

Read investment analysis: OPCH · THC · ENSG · PNTG · UHS · CHE · LFST · CCM · PIII · ADUS · NHC

Which Other Stocks Have a Similar Quality Score to NUTX?

7 companies across all industries closest to NUTX’s Quality of Company score of 8.4/10.

TTCThe Toro CompanyQOC 8.4MITKMitek Systems, Inc.QOC 8.3ATROAstronics CorporationQOC 8.4SMBKSmartFinancial, Inc.QOC 8.3CHTRCharter Communications, Inc.QOC 8.4SFBSServisFirst Bancshares, Inc.QOC 8.3NVDANVIDIA CorporationQOC 10.0

Read investment analysis: TTC · MITK · ATRO · SMBK · CHTR · SFBS · NVDA

Where Does NUTX Sit in CirclFi's Medical Care Facilities Rankings?

NUTX is ranked against every other Medical Care Facilities stock CirclFi covers in each of these screens.

See all Medical Care Facilities stocks ranked →

What Else Do Investors Ask About Nutex Health Inc.’s Valuation?

What is Nutex Health Inc.'s intrinsic value in 2026?

CirclFi puts Nutex Health Inc. (NUTX)'s intrinsic value at $251.83 — the median of 9 independent model estimates as of 2026-08-28, ranging from $85.09 to $600.78. One component of that median, the Bayesian DCF, runs 10,000 Monte Carlo simulations with jump-diffusion and returns $132.02 on its own. The Quality of Company score is 8.4/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is NUTX overvalued or undervalued right now?

At $189.25, 5 of 9 active models suggest NUTX may be undervalued, while 4 indicate potential overvaluation. The median of all 9 fair value estimates is $251.83, 33.1% above the current price of $189.25 — a consensus view that NUTX is undervalued. The assessment depends on which methodology best fits Nutex Health Inc.'s business model in Medical Care Facilities.

What does a Quality of Company score of 8.4 mean for NUTX?

Nutex Health Inc.'s QOC of 8.4/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores above 7 indicate strong fundamentals and disciplined management.

How many valuation models does CirclFi run on NUTX?

CirclFi analyzes NUTX with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 9 of 13 are active for this stock. Read the full methodology →

Which valuation models are most bullish and most bearish on NUTX?

Of the 9 models currently active on NUTX, First Chicago is the most bullish at $600.78 per share, and ML Residual Income is the most bearish at $85.09. CirclFi's published fair value for NUTX is the median of that range, $251.83, not either extreme. The gap between the two ends equals 205% of the median — a wide spread, meaning the methods genuinely disagree and the median should carry less weight. Browse stocks by value-trap risk →

Is NUTX a value trap in 2026?

Nutex Health Inc.'s Value Trap score is 18/100 (SAFE). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap.

Cite this analysis — “According to CirclFi’s 9-model valuation engine, Nutex Health Inc. (NUTX) has a median fair value of $251.83 — 33.1% above the current price of $189.25 — as of 2026-08-28.” Source: circlfi.com/stock/NUTX/ · Methodology
Primary sources for this NUTX valuation
  • Financial statements: Nutex Health Inc. 10-K and 10-Q filings on SEC EDGAR (CIK 0001479681) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for NUTX as of ; valuations recomputed .

You’ve done the research. Don’t stop at half the picture.

Stop collecting opinions. Let 9 mathematical frameworks give you clarity on NUTX.

Unlock All 9 Fair Values — $39/mo

Cancel anytime · Less than a cup of coffee · Instant access

5 models hidden for NUTX Unlock All 9 — $39/mo